File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Direct medical costs of diabetes mellitus in the year of mortality and year before mortality

TitleDirect medical costs of diabetes mellitus in the year of mortality and year before mortality
Authors
Keywordscohort study
cost-effectiveness
database research
primary care
type 2 diabetes
Issue Date2018
PublisherWiley-Blackwell Publishing Ltd. The Journal's web site is located at http://www.blackwellpublishing.com/journals/DOM
Citation
Diabetes, Obesity and Metabolism, 2018, v. 20 n. 6, p. 1470-1478 How to Cite?
AbstractAims: Studies have shown that health service utilization often increases in few years immediately before death. Estimates of direct medical cost of diabetes mellitus (DM) in mortality year and the previous year is not well understood. This study aimed to report the health resource use and estimate the direct medical costs among DM patients in the year of mortality and the year before mortality. Materials and Methods: We analysed a population-based, retrospective cohort study including all adults with DM diagnosis in Hong Kong between 2009 and 2013, and death between January 1, 2010 and December 31, 2013. Annual direct medical costs in year of mortality and year before mortality were determined by summing costs of health services utilized within the respective year. The costs were analysed by gender, the presence of co-morbidities, diabetic complications and primary cause of death. Results: A total of 10,649 patients met the eligibility criteria for analysis. On average, the direct medical costs in the year of death were 1.947 times higher than those in the year before death. Male and female patients had similar costs in the year before mortality and mortality year. Patients with any diabetic complications had greater costs in the year of mortality and before mortality than those without. Conclusions: This analysis provides new evidence on incorporating additional direct medical costs in the mortality year, and refining the structure of total cost estimates for use in costing and cost-effectiveness analyses of interventions for DM.
Persistent Identifierhttp://hdl.handle.net/10722/251440
ISSN
2021 Impact Factor: 6.408
2020 SCImago Journal Rankings: 2.445
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorWong, CKH-
dc.contributor.authorJiao, F-
dc.contributor.authorTang, HM-
dc.contributor.authorTong, T-
dc.contributor.authorThokala, P-
dc.contributor.authorLam, CLK-
dc.date.accessioned2018-03-01T03:39:20Z-
dc.date.available2018-03-01T03:39:20Z-
dc.date.issued2018-
dc.identifier.citationDiabetes, Obesity and Metabolism, 2018, v. 20 n. 6, p. 1470-1478-
dc.identifier.issn1462-8902-
dc.identifier.urihttp://hdl.handle.net/10722/251440-
dc.description.abstractAims: Studies have shown that health service utilization often increases in few years immediately before death. Estimates of direct medical cost of diabetes mellitus (DM) in mortality year and the previous year is not well understood. This study aimed to report the health resource use and estimate the direct medical costs among DM patients in the year of mortality and the year before mortality. Materials and Methods: We analysed a population-based, retrospective cohort study including all adults with DM diagnosis in Hong Kong between 2009 and 2013, and death between January 1, 2010 and December 31, 2013. Annual direct medical costs in year of mortality and year before mortality were determined by summing costs of health services utilized within the respective year. The costs were analysed by gender, the presence of co-morbidities, diabetic complications and primary cause of death. Results: A total of 10,649 patients met the eligibility criteria for analysis. On average, the direct medical costs in the year of death were 1.947 times higher than those in the year before death. Male and female patients had similar costs in the year before mortality and mortality year. Patients with any diabetic complications had greater costs in the year of mortality and before mortality than those without. Conclusions: This analysis provides new evidence on incorporating additional direct medical costs in the mortality year, and refining the structure of total cost estimates for use in costing and cost-effectiveness analyses of interventions for DM.-
dc.languageeng-
dc.publisherWiley-Blackwell Publishing Ltd. The Journal's web site is located at http://www.blackwellpublishing.com/journals/DOM-
dc.relation.ispartofDiabetes, Obesity and Metabolism-
dc.rightsPostprint This is the peer reviewed version of the following article: [Diabetes, Obesity and Metabolism, 2018, v. 20 n. 6, p. 1470-1478], which has been published in final form at [http://dx.doi.org/10.1111/dom.13253]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.-
dc.subjectcohort study-
dc.subjectcost-effectiveness-
dc.subjectdatabase research-
dc.subjectprimary care-
dc.subjecttype 2 diabetes-
dc.titleDirect medical costs of diabetes mellitus in the year of mortality and year before mortality-
dc.typeArticle-
dc.identifier.emailWong, CKH: carlosho@hku.hk-
dc.identifier.emailJiao, F: francesj@connect.hku.hk-
dc.identifier.emailTang, HM: erichm@hku.hk-
dc.identifier.emailLam, CLK: clklam@hku.hk-
dc.identifier.authorityWong, CKH=rp01931-
dc.identifier.authorityLam, CLK=rp00350-
dc.description.naturepostprint-
dc.identifier.doi10.1111/dom.13253-
dc.identifier.pmid29430799-
dc.identifier.scopuseid_2-s2.0-85046824404-
dc.identifier.hkuros284342-
dc.identifier.volume20-
dc.identifier.issue6-
dc.identifier.spage1470-
dc.identifier.epage1478-
dc.identifier.isiWOS:000431942800019-
dc.publisher.placeUnited Kingdom-
dc.identifier.issnl1462-8902-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats